van Olden R W, van Acker B A, Koomen G C, Krediet R T, Arisz L
Department of Medicine, University of Amsterdam, The Netherlands.
Clin Nephrol. 1998 Mar;49(3):167-72.
The clearance of organic ions by the tubules may contribute to the removal of uremic waste products in dialysis patients. The renal excretion of an exogenous anion p-aminohippurate (PAH) was investigated in 10 peritoneal dialysis patients and 10 hemodialysis patients during one clearance period and compared with the clearance of creatinine (Ccr) and inulin (CIn). The clearance period was 24 hours in the peritoneal dialysis patients and one interdialytic interval of 3 days divided in 4 parts [CPA-D] in hemodialysis patients. In peritoneal dialysis patients the renal clearance of total PAH (median 14.3 ml/min, range 3.8-33.0) exceeded the CIN (median 3.2 ml/min, range 1.6-11.2, p < 0.005) and Ccr (median 4.0 ml/min, range 1.7-15.0, p < 0.005). A positive correlation was found between the tubular clearances of creatinine (cationic pathway) and of total PAH (anionic pathway, r: 0.72, p <0.02). In hemodialysis patients the clearance of total PAH (CPA: median 2.0, range 0.8-9.6; CPD: median 3.8, range 1.7-15.4) also exceeded the clearance of inulin (CPA: median 1.5, range 0.2-3.4; CPD: median 2.7, range 0.9-4.4) in the beginning and the end of the interdialytic interval (p < 0.005). The CIN and the clearance of total PAH increased during the interdialytic interval, but the Ccr (CPA: median 2.2, range 0.4-8.9, CPD: median 2.9, range 1.2-4.6) remained stable. Thus, the change in tubular clearance of creatinine and PAH was opposite during the interdialytic interval: it increased for total PAH and decreased for creatinine. The CTPAH/CIN ratio in hemodialysis patients was lower than in peritoneal dialysis patients. In CPA it was median 1.6 (range 1.1-5.6, p < 0.05) and in CPD it was median 1.7 (range 1.1-5.0, p < 0.02) and in the peritoneal dialysis patients it was median 3.6 (range 1.5-9.1). We conclude that tubular clearances contribute to the residual renal function in dialysis patients, but the tubular handling of anions and cations in relation to the residual GFR is different between peritoneal and hemodialysis patients. A difference in clearance of organic acids caused by the dialysis techniques may be an explanation for the differences in clinical outcome between the two dialysis modalities.
肾小管对有机离子的清除作用可能有助于透析患者清除尿毒症废物。在一个清除期内,对10例腹膜透析患者和10例血液透析患者的外源性阴离子对氨基马尿酸(PAH)的肾排泄情况进行了研究,并与肌酐清除率(Ccr)和菊粉清除率(CIn)进行比较。腹膜透析患者的清除期为24小时,血液透析患者的清除期为3天的透析间期,分为4个部分[CPA - D]。在腹膜透析患者中,总PAH的肾清除率(中位数14.3 ml/min,范围3.8 - 33.0)超过了CIN(中位数3.2 ml/min,范围1.6 - 11.2,p < 0.005)和Ccr(中位数4.0 ml/min,范围1.7 - 15.0,p < 0.005)。发现肌酐(阳离子途径)和总PAH(阴离子途径)的肾小管清除率之间存在正相关(r:0.72,p <0.02)。在血液透析患者中,透析间期开始和结束时,总PAH的清除率(CPA:中位数2.0,范围0.8 - 9.6;CPD:中位数3.8,范围1.7 - 15.4)也超过了菊粉清除率(CPA:中位数1.5,范围0.2 - 3.4;CPD:中位数2.7,范围0.9 - 4.4)(p < 0.005)。CIN和总PAH的清除率在透析间期增加,但Ccr(CPA:中位数2.2,范围0.4 - 8.9,CPD:中位数2.9,范围1.2 - 4.6)保持稳定。因此,在透析间期,肌酐和PAH的肾小管清除率变化相反:总PAH增加,肌酐减少。血液透析患者的CTPAH/CIN比值低于腹膜透析患者。在CPA中,中位数为1.6(范围1.1 - 5.6,p < 0.05),在CPD中,中位数为1.7(范围1.1 - 5.0,p < 0.02),而在腹膜透析患者中,中位数为3.6(范围1.5 - 9.1)。我们得出结论,肾小管清除率对透析患者的残余肾功能有贡献,但腹膜透析和血液透析患者中阴离子和阳离子的肾小管处理与残余肾小球滤过率的关系不同。透析技术导致的有机酸清除差异可能是两种透析方式临床结局差异的一个解释。